Premium
Edgewise Therapeutics Inc (EWTX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-04 | Dr. Joanne M. DonovanChief Medical Officer | -5,23k | 163,66k | Automatic Disposition | 31,29 | 4,37k | -54,50% |
| 2026-05-05 | Dr. Joanne M. DonovanChief Medical Officer | -50,00k | 1,57M | Derivative Exercise and Sale | 7,08 - 38,57 | 4,37k | - |
| 2026-04-01 | Dr. Joanne M. DonovanChief Medical Officer | -28,66k | 723,17k | Derivative Exercise and Sale | 7,08 - 32,31 | 9,60k | - |
| 2026-03-31 | Dr. Joanne M. DonovanChief Medical Officer | -21,34k | 534,24k | Derivative Exercise and Sale | 7,08 - 32,12 | 9,60k | - |
| 2026-03-27 | Dr. Joanne M. DonovanChief Medical Officer | -16,36k | 506,73k | Vente | 30,98 | 9,60k | -63,02% |
| 2026-01-21 | Dr. Badreddin EdrisCo-Founder & Independent Director | -115,47k | 3,23M | Derivative Exercise and Sale | 0,39 - 29,44 | 19,82k | - |
| 2025-11-12 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | -100,00k | 2,09M | Derivative Exercise and Sale | 0,18 - 21,12 | 23,40k | - |
| 2025-11-11 | Dr. Jonathan C. FoxIndependent Director | 10,70k | 199,40k | Achat | 18,64 | 23,70k | 82,30% |
| 2025-08-26 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | -100,00k | 1,44M | Derivative Exercise and Sale | 0,18 - 14,60 | 23,40k | - |
| 2025-08-12 | Mr. John R. MooreGeneral Counsel | 3,68k | 0,00 | Derivative Exercise and Retained Stock | - | 10,21k | 56,39% |
| 2025-08-12 | Mr. John R. MooreGeneral Counsel | -2,10k | 28,10k | Derivative Exercise and Sale | 13,39 | 10,21k | - |
| 2025-08-12 | Dr. Behrad DerakhshanCOO | 3,29k | 0,00 | Derivative Exercise and Retained Stock | - | 23,65k | 16,16% |
| 2025-08-12 | Dr. Behrad DerakhshanCOO | -2,49k | 33,36k | Derivative Exercise and Sale | 13,39 | 23,65k | - |
| 2025-08-12 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 23,40k | 19,84% |
| 2025-08-12 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | -1,91k | 25,54k | Derivative Exercise and Sale | 13,39 | 23,40k | - |
| 2025-08-12 | Mr. R. Michael CarruthersInitié | 4,35k | 0,00 | Derivative Exercise and Retained Stock | - | 86,16k | 5,32% |
| 2025-08-12 | Mr. R. Michael CarruthersInitié | -1,43k | 19,12k | Derivative Exercise and Sale | 13,39 | 86,16k | - |
| 2025-08-12 | Dr. Joanne M. DonovanChief Medical Officer | 2,92k | 0,00 | Derivative Exercise and Retained Stock | - | 25,36k | 13,01% |
| 2025-08-12 | Dr. Joanne M. DonovanChief Medical Officer | -2,86k | 38,33k | Derivative Exercise and Sale | 13,39 | 25,36k | - |
| 2025-08-12 | Dr. Kevin KochPresident, CEO & Director | 10,00k | 0,00 | Derivative Exercise and Retained Stock | - | 369,40k | 2,78% |
| 2025-08-12 | Dr. Kevin KochPresident, CEO & Director | -7,97k | 106,76k | Derivative Exercise and Sale | 13,39 | 369,40k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
